SCHEMBL30457671

SCHEMBL30457671

CCCC(C)(C)OOCCOC(=O)O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2489893 0.89 ALDH1A1 (0.34) LMNAHSD17B10
SCHEMBL986351 0.89 NAAA (0.35) LMNAHSD17B10
SCHEMBL30457817 0.89 DGKA (0.35)
SCHEMBL30457392 0.85 TSHR (0.32)
SCHEMBL30456614 0.83 LMNA (0.36) LMNAHSD17B10
SCHEMBL31055388 0.81 NAAA (0.38)
SCHEMBL31164259 0.81 ALDH1A1 (0.37)
SCHEMBL30456946 0.79
SCHEMBL2829466 0.78 DGKA (0.61) LMNA
SCHEMBL9438062 0.78 TSHR (0.31) HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692177-A1 RESIN POWDER AND METHOD FOR PRODUCING SAME Kaneka Corporation (JP) 2026-02-11 EP disclosed
US-20250388748-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-12-25 US disclosed
EP-4610313-A1 THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2025-09-03 EP disclosed
US-20250250435-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-08-07 US disclosed
US-20250243321-A1 METHOD FOR PRODUCING MODIFIED ALIPHATIC OR ALIPHATIC-AROMATIC THERMOPLASTIC POLYESTER RESIN KANEKA CORPORATION (JP) 2025-07-31 US disclosed
US-20250230273-A1 CROSSLINKED RESIN PARTICLES AND METHOD FOR PRODUCING THE SAME KANEKA CORPORATION (JP) 2025-07-17 US disclosed
US-20250215215-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-07-03 US disclosed
US-20250066538-A1 MODIFIED ALIPHATIC POLYESTER RESIN AND COMPOSITION OR MOLDED ARTICLE THEREOF KANEKA CORPORATION (JP) 2025-02-27 US disclosed
EP-4506395-A1 CROSSLINKED RESIN PARTICLES AND METHOD FOR PRODUCING SAME Kaneka Corporation (JP) 2025-02-12 EP disclosed
EP-4502081-A1 THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2025-02-05 EP disclosed
EP-4502082-A1 THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2025-02-05 EP disclosed
EP-4467589-A1 MODIFIED ALIPHATIC POLYESTER-BASED RESIN AND COMPOSITION OR MOLDED BODY THEREOF Kaneka Corporation (JP) 2024-11-27 EP disclosed
EP-4467590-A1 METHOD FOR MANUFACTURING MODIFIED ALIPHATIC OR ALIPHATIC AROMATIC THERMOPLASTIC POLYESTER RESIN Kaneka Corporation (JP) 2024-11-27 EP disclosed
US-20230323114-A1 ALIPHATIC-POLYESTER-BASED RESIN COMPOSITION AND UTILIZATION THEREOF KANEKA CORPORATION (JP) 2023-10-12 US disclosed
WO-2023190185-A1 THERMOPLASTIC RESIN COMPOSITION 株式会社カネカ 2023-10-05 WO disclosed
WO-2023190184-A1 THERMOPLASTIC RESIN COMPOSITION 株式会社カネカ 2023-10-05 WO disclosed
WO-2023190183-A1 CROSSLINKED RESIN PARTICLES AND METHOD FOR PRODUCING SAME 株式会社カネカ 2023-10-05 WO disclosed
EP-4183828-A1 ALIPHATIC-POLYESTER-BASED RESIN COMPOSITION AND UTILIZATION THEREOF Kaneka Corporation (JP) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388748-A1 THERMOPLASTIC RESIN COMPOSITION HSPA4L, HSP90AA1, HACD3 LMNA 3742/4885HSD17B10 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.